Patients' perceptions toward and the driving factors of decision-making for opportunistic bilateral salpingectomy at the time of cesarean section

Murat Yassa, Çiğdem Pulatoğlu, Murat Yassa, Çiğdem Pulatoğlu

Abstract

Objective: Enough data can be found in the literature regarding the protective effect of tubal ligation on gynecological cancers. In addition, a large body of evidence revealed that prophylactic bilateral salpingectomy had no significant negative effect on the ovarian function, quality of life, sexuality, surgery duration, and cost-effectivity. This study was aimed at exploring the underlying factors that motivate women for either opportunistic bilateral salpingectomy (OBS) or tubal ligation, particularly focusing on their preferences, knowledge, and beliefs toward female sterilization, satisfaction from counseling, and body image following the salpingectomy.

Materials and methods: A total of 54 patients who had undergone surgical sterilization with either OBS or tubal ligation were included in this prospective cohort study. The acceptance rate of the OBS at the time of cesarean section among pregnant women seeking surgical sterilization was calculated. The underlying reasons for women's acceptance or refusal for salpingectomy were assessed by a non-validated data collection tool that had 14 open-ended questions focusing on the women's preferences, knowledge, beliefs toward female sterilization, satisfaction from counseling, and body image following the salpingectomy.

Results: The acceptance rate of OBS at the time of cesarean section among pregnant women and electively among non-pregnant women were 93.5% (n=43/46) and 75% (6/8), respectively. The main driving factors influencing the decision of preferring OBS over tubal ligation were the risk-reducing effect for ovarian cancer and superior pregnancy prevention.

Conclusion: The acceptance rate of OBS at the time of cesarean section was found to be very high, and it should therefore be offered at the time of cesarean section to women who desire permanent contraception.

Keywords: Opportunistic salpingectomy; permanent contraception; postpartum sterilization; prophylactic salpingectomy; risk-reducing salpingectomy.

Conflict of interest statement

Conflict of Interest: No conflict of interest was declared by the authors.

©Copyright 2020 by Turkish Society of Obstetrics and Gynecology | Turkish Journal of Obstetrics and Gynecology published by Galenos Publishing House.

Figures

Figure 1
Figure 1
Flowchart of the women included in the study
Figure 2
Figure 2
The reason for women’s preference of tubal surgery
Figure 3
Figure 3
Women’s knowledge of other contraception methods
Figure 4
Figure 4
Women’s knowledge toward the reversal of tubal ligation
Figure 5
Figure 5
Underlying reasons for not choosing oral contraceptives
Figure 6
Figure 6
Women’s religious beliefs toward the salpingectomy
Figure 7
Figure 7
Women’s religious beliefs toward the tubal ligation
Figure 8
Figure 8
Women’s knowledge of the future treatment options following the salpingectomy
Figure 9
Figure 9
Women’s knowledge of the success for future ART following the salpingectomy
Figure 10
Figure 10
Women’s main motivation for having tubal sterilization
Figure 11
Figure 11
Decision-making on having tubal sterilization
Figure 12
Figure 12
Women’s main motivation for having salpingectomy instead of tubal ligation
Figure 13
Figure 13
Underlying reasons for refusing salpingectomy
Figure 14
Figure 14
Women’s satisfaction with the detailed counseling on salpingectomy
Figure 15
Figure 15
Women’s body image upon salpingectomy

References

    1. Patil E, Jensen JT. Update on Permanent contraception options for women: Current Opinion in Obstetrics and Gynecology. Curr Opin Obstet Gynecol. 2015;27:465–70.
    1. Chan LM, Westhoff CL. Tubal sterilization trends in the United States. Fertil Steril. 2010;94:1–6.
    1. Peterson HB, Xia Z, Hughesa JM, Wilcox LS, Tylora LR, Trussell J. The risk of pregnancy after tubal sterilization: findings from the US Collaborative Review of Sterilization. Am J Obstet Gynecol. 1996;174:1161–8; discussion 1168-70.
    1. Loghmani L, Saedi N, Omani-Samani R, Safiri S, Sepidarkish M, Maroufizadeh S, et al. Tubal ligation and endometrial Cancer risk: a global systematic review and meta-analysis. BMC Cancer. 2019;19:942.
    1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.
    1. Shih I-M, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511–8.
    1. Anggraeni TD, Al Fattah AN, Surya R. Prophylactic salpingectomy and ovarian cancer: an evidence-based analysis. South Asian J Cancer. 2018;7:42–5.
    1. Subramaniam A, Blanchard CT, Erickson BK, Szychowski J, Leath CA, Biggio JR, et al. Feasibility of complete salpingectomy compared with standard postpartum tubal ligation at cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2018;132:20–7.
    1. Subramaniam A, Einerson BD, Blanchard CT, Erickson BK, Szychowski J, Leath III CA, et al. The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction. Gynecol Oncol. 2019;152:127–32.
    1. Subramaniam A, Blanchard C, Erickson B, Szychowski J, Leath C, Biggio J, et al. Factors associated with completion and physician and patient attitudes towards salpingectomy at the time of cesarean delivery. Gynecol Oncol. 2018;149:77.
    1. Piazza A, Schwirian K, Scott F, Wilson MD, Zite NB, Creinin MD. Women’s preferences for permanent contraception method and willingness to be randomized for a hypothetical trial. Contraception. 2019;99:56–60.
    1. Borrero S, Nikolajski C, Rodriguez KL, Creinin MD, Arnold RM, Ibrahim SA. “Everything I know I learned from my mother. or not”: perspectives of African-American and white women on decisions about tubal sterilization. J Gen Intern Med. 2009;24:312–9.
    1. Committee on Gynecologic Practice. Committee opinion no. 620: Salpingectomy for ovarian cancer prevention. Obstet Gynecol. 2015;125:279–81.
    1. Venkatesh KK, Clark LH, Stamilio DM. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery. Am J Obstet Gynecol. 2019;220:106.e1–106.e10.
    1. Polen-De C, Meganathan K, Lang P, Hohmann S, Jackson A, Whiteside JL. Nationwide salpingectomy rates for an indication of permanent contraception before and after published practice guidelines. Contraception. 2019;100:111–5.
    1. Ferrari F, Forte S, Prefumo F, Sartori E, Odicino F. Opportunistic salpingectomy during postpartum contraception procedures at elective and unscheduled cesarean delivery. Contraception. 2019;99:373–6.
    1. Garcia C, Martin M, Tucker L-Y, Lyon L, Armstrong MA, McBride- Allen S, et al. Experience with opportunistic salpingectomy in a large, community-based health system in the United States. Obstet Gynecol. 2016;128:277–83.
    1. Yang M, Du Y, Hu Y. Complete salpingectomy versus tubal ligation during cesarean section: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2019:1–9.
    1. Roeckner JT, Sawangkum P, Sanchez-Ramos L, Duncan JR. Salpingectomy at the time of cesarean delivery: a systematic review and meta-analysis. Obstet Gynecol. 2020;135:550–7.
    1. Bartz D, Greenberg JA. Sterilization in the United States. Rev Obstet Gynecol. 2008;1:23–32.

Source: PubMed

3
Předplatit